Navigation Links
Pinning protein could answer provocative cancer question
Date:10/30/2012

HOUSTON -- (Oct. 29, 2012) -- Answers are often elusive in the fight against cancer, and Rice University chemist Zachary Ball is hoping to pin one down -- with pins made of single atoms. The work, which aims to create a drug that's effective against an "undruggable" protein, is one of the first 50 proposals funded under the National Cancer Institute's (NCI) Provocative Questions Project.

The Provocative Questions Project, in its inaugural year, is designed to spur innovative approaches to critical questions that could, if answered, substantially change the way scientists approach cancer research. Ball, assistant professor of chemistry at Rice, and collaborators at Baylor College of Medicine (BCM) are attempting to answer one of 24 questions posed by NCI: "Are there new technologies to inhibit traditionally 'undruggable' target molecules, such as transcription factors, that are required for (cancer)?"

"Most drugs are small molecules that bind tightly to a protein and literally get in the way of it sticking to whatever it might normally interact with, often another protein," Ball said. "Drugs tend to be small molecules because those are the easiest to introduce into cells and because small molecules are particularly effective at binding tightly into the tiny pockets that exist on many proteins."

Unfortunately, there are some proteins that don't have the tiny pockets favored by drug designers. By some estimates, small-molecule drugs are ineffective against as many as 80 percent of the proteins in human cells, including many signaling proteins and a class of proteins called transcription factors that help control basic functions like cell death and cell reproduction. Drugmakers often call these proteins "undruggable."

"Researchers have actually spent a good deal of time and effort looking for drug candidates that are effective against some of these undruggable targets," Ball said. "But the results are generally mediocre, and affinity is a big reason why. Without a classical binding pocket, we tend to see inefficient binding with relatively flat protein surfaces that are not designed to bind drug-like molecules. Our idea is to add well-placed rhodium atoms that will act like pins to hold an otherwise mediocre drug candidate in place."

The NCI project grew out of a collaboration with Michele Redell, assistant professor of internal medicine at BCM, and David Tweardy, professor of medicine and chief of the section of infectious diseases at BCM. Ball, Redell and Tweardy won seed funding in January from the Simmons Family Foundation for a project aimed at developing new drugs to treat acute myeloid leukemia (AML), which afflicts thousands of new patients every year, many of them children.

In particular, the group was interested in modifying a drug candidate compound to improve its effectiveness against STAT3, a transcription regulating protein that has been implicated in AML and numerous other cancers, including gastric, renal, breast, ovarian, skin and brain cancer. STAT3 is an especially compelling area of study because previous research has shown that targeting STAT3 may allow for effective treatment of "multiple drug-resistant" tumors for which available treatments are ineffective.

"The Simmons grant allowed us to gather preliminary evidence to bolster our case for creating a hybrid drug that combines the benefits of both traditional drugs and metal-based drugs," Ball said. "The prior work really strengthened our proposal, and we're hoping to use the two-year 'Provocative Questions' grant to lay the scientific foundations for future translational studies."


'/>"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
Source:Eurekalert  

Related medicine news :

1. Salk study finds diabetes raises levels of proteins linked to Alzheimers features
2. Protein regulation linked to intellectual disability
3. Lactation protein suppresses tumors and metastasis in breast cancer
4. Treating Sperm With Missing Protein Might Help Male Fertility
5. Research identifies protein that regulates key fate decision in cortical progenitor cells
6. Cervical cancer and pre-cancer cervical growths require single HPV protein
7. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
8. Hopkins scientists discover how an out-of-tune protein leads to muscle demise in heart failure
9. Protein linked to therapy resistance in breast cancer
10. Well-known protein reveals new tricks
11. Binding sites for LIN28 protein found in thousands of human genes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pinning protein could answer provocative cancer question
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished ... the Outlier Leadership Series, Outliers in Writing, set to publish in summer 2017. ... Medicine at the University of Arizona College of Medicine. He also serves as Medical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
Breaking Medicine Technology: